Company profile
ikarovec
ikarovec is a UK-based biotech gene therapy company with a therapeutic focus in ophthalmology.
- Industry
- Biotechnology Research
- Employees
- 8
- Headquarters
- Norwich
- Founded
- 2018
- Office locations
- 1
ikarovec company summary
ikarovec is a company in the Biotechnology Research industry, headquartered in Norwich, founded in 2018. On LinkedIn the company has around 8 employees. Its listed specialties include gene therapy, ophthalmology, diabetic macular edema (DME), wet age-related macular degeneration, geographic atrophy.
What technology does ikarovec use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About ikarovec
The company has an early stage pipeline of novel, multi-cistronic gene therapy products targeting diabetic macular edema (DME), age-related macular degeneration (AMD, both wet and dry forms) and ocular hypertension.
Specialties
Where is ikarovec located?
ikarovec lists 1 location.
Compare companies similar to ikarovec
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
ikarovec ikarovec.com | Biotechnology Research | 8 | 2018 | Norwich |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about ikarovec
What does ikarovec do?
The company has an early stage pipeline of novel, multi-cistronic gene therapy products targeting diabetic macular edema (DME), age-related macular degeneration (AMD, both wet and dry forms) and ocular hypertension.
How many employees does ikarovec have?
ikarovec has around 8 employees on LinkedIn.
Where is ikarovec headquartered?
ikarovec is headquartered in Norwich.
When was ikarovec founded?
ikarovec was founded in 2018.
Build a lead list from companies like ikarovec
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.